Founded in 1906, Norgine is a leading European specialist pharmaceutical company with a strong global network of partnerships. This enables us to acquire, develop and commercialise innovative products that make a real difference to the lives of patients.

Please note that the products mentioned below may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. To report an adverse event, please click here to send this information to [email protected] For all product queries, please email [email protected]

Norgine is a leading European specialist pharmaceutical company that has been bringing transformative products to patients for over a century.

LONDON, Dec. 15, 2022 /PRNewswire/ -- Today, Norgine Europe B.V. ("Norgine", the "Company"), a leading European specialty pharmaceutical company, announced that the Private Equity business...

2025年1月14日 · X4 and Norgine will collaborate closely on regulatory filings, with X4 continuing to be responsible for the ongoing global, pivotal Phase 3 4WARD clinical trial evaluating mavorixafor in CN.

Norgine is a uniquely positioned, specialty pharmaceutical and consumer healthcare company, with more than €500 million of annual revenues and a 120-year track record of bringing...

2024年4月16日 · Norgine has sought approval for eflornithine (difluoromethylornithine [DFMO]) for the treatment of patients with high-risk neuroblastoma (HRNB). The development marks the first marketing authorisation applications submitted in Australia, Switzerland and the UK seeking approval for the drug.

Transforming Healthcare, Backed by Over a Century of Expertise | Norgine is a leading European specialist pharmaceutical company that has been bringing transformative medicines to patients for...

Bringing transformative medicines to patients for over a century. This information is intended to assist healthcare professionals make decisions about treatment options and provide …

Manufacturer of specialty pharmaceutical products focused on adding value and benefits to healthcare systems and patients.

Norgine is a leading European specialist pharmaceutical company that has been established for over a century and has a presence in all major European markets, Australia and New Zealand.

Norgine is a pharmaceutical company specializing in transformative medicines. It provides expertise in gastroenterology from macrogol-based laxatives to bowel preparation, offers early detection and management of hepatic encephalopathy, improves the diagnosis of patients with head and neck cancer.

We operate a single integrated business with a direct presence in all major markets in Europe, Australia and New Zealand, with a coverage of the entire market. Norgine is headquartered in the Netherlands.

2025年1月13日 · Norgine is a uniquely positioned, specialty pharmaceutical and consumer healthcare company, with more than €500 million of annual revenues and a 120-year track record of bringing...

Founded in 1906, Norgine is a leading European specialist pharmaceutical company with a strong global network of partnerships. This enables us to acquire, develop and commercialise innovative products that make a real difference to the lives of patients.

Norgine is a European specialist pharmaceutical company with a direct commercial presence in all major European markets. They operate a well-established European infrastructure to develop, manufacture and commercialise products.

Norgine is a leading European specialist pharmaceutical company that has been bringing transformative products to patients for over a century. Our commitment to transforming people’s lives drives everything we do and our European experience, fully integrated infrastructure and exceptional partnership approach enables us to quickly apply creative solutions to bring life …

6 天之前 · Gegenanzeigen von MACROGOL Norgine Junior neutral Plv.z.H.L.z.Einn. Beschreibt, welche Erkrankungen oder Umstände gegen eine Anwendung des Arzneimittels sprechen, in welchen Altersgruppen das Arzneimittel nicht eingesetzt werden sollte/darf und ob Schwangerschaft und Stillzeit gegen die Anwendung des Arzneimittels sprechen.